230 related articles for article (PubMed ID: 31112957)
1. Levofloxacin for NIH Category II Chronic Bacterial Prostatitis: A Real-Life Study.
Magri V; Perletti G; Cai T; Stamatiou K; Trinchieri A; Montanari E
Chemotherapy; 2019; 64(1):8-16. PubMed ID: 31112957
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial therapy for chronic bacterial prostatitis.
Perletti G; Marras E; Wagenlehner FM; Magri V
Cochrane Database Syst Rev; 2013 Aug; (8):CD009071. PubMed ID: 23934982
[TBL] [Abstract][Full Text] [Related]
3. Eradication of Chlamydia trachomatis parallels symptom regression in chronic bacterial prostatitis patients treated with a fluoroquinolone-macrolide combination.
Magri V; Marras E; Skerk V; Markotić A; Restelli A; Garlaschi MC; Perletti G
Andrologia; 2010 Dec; 42(6):366-75. PubMed ID: 21105887
[TBL] [Abstract][Full Text] [Related]
4. Serenoa repens associated with selenium and lycopene extract and bromelain and methylsulfonylmethane extract are able to improve the efficacy of levofloxacin in chronic bacterial prostatitis patients.
Cai T; Tiscione D; Gallelli L; Verze P; Palmieri A; Mirone V; Bartoletti R; Malossini G
Arch Ital Urol Androl; 2016 Oct; 88(3):177-182. PubMed ID: 27711089
[TBL] [Abstract][Full Text] [Related]
5. Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection.
Magri V; Trinchieri A; Montanari E; Del Nero A; Mangiarotti B; Zirpoli P; de Eguileor M; Marras E; Ceriani I; Vral A; Perletti G
Arch Ital Urol Androl; 2007 Jun; 79(2):84-92. PubMed ID: 17695414
[TBL] [Abstract][Full Text] [Related]
6. Prostatic calcifications are associated with a more severe symptom burden in men with type II chronic bacterial prostatitis.
Stamatiou K; Magri V; Perletti G; Trinchieri A; Lacroix R; Rekleiti N; Moschouris H
Arch Ital Urol Androl; 2019 Jul; 91(2):. PubMed ID: 31266275
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome.
Wang J; Yan D; Liang K; Xu Z
Int Urol Nephrol; 2016 Jan; 48(1):13-8. PubMed ID: 26577998
[TBL] [Abstract][Full Text] [Related]
8. Aminoglycoside antibiotics for NIH category II chronic bacterial prostatitis: A single-cohort study with one-year follow-up.
Magri V; Montanari E; Marras E; Perletti G
Exp Ther Med; 2016 Oct; 12(4):2585-2593. PubMed ID: 27698761
[TBL] [Abstract][Full Text] [Related]
9. Fluoroquinolone-macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunction.
Magri V; Montanari E; Škerk V; Markotić A; Marras E; Restelli A; Naber KG; Perletti G
Asian J Androl; 2011 Nov; 13(6):819-27. PubMed ID: 21765442
[TBL] [Abstract][Full Text] [Related]
10. Identification, pharmacologic considerations, and management of prostatitis.
Schiller DS; Parikh A
Am J Geriatr Pharmacother; 2011 Feb; 9(1):37-48. PubMed ID: 21459307
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of levofloxacin 750 mg for 2 weeks or 3 weeks compared with levofloxacin 500 mg for 4 weeks in treating chronic bacterial prostatitis.
Paglia M; Peterson J; Fisher AC; Qin Z; Nicholson SC; Kahn JB
Curr Med Res Opin; 2010 Jun; 26(6):1433-41. PubMed ID: 20394471
[TBL] [Abstract][Full Text] [Related]
12. Prulifloxacin versus levofloxacin in the treatment of chronic bacterial prostatitis: a prospective, randomized, double-blind trial.
Giannarini G; Mogorovich A; Valent F; Morelli G; De Maria M; Manassero F; Barbone F; Selli C
J Chemother; 2007 Jun; 19(3):304-8. PubMed ID: 17594926
[TBL] [Abstract][Full Text] [Related]
13. Oral levofloxacin 500 mg once daily in the treatment of chronic bacterial prostatitis.
Naber KG; Roscher K; Botto H; Schaefer V
Int J Antimicrob Agents; 2008 Aug; 32(2):145-53. PubMed ID: 18571904
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological features and resistance pattern in uropathogens isolated from chronic bacterial prostatitis.
Cai T; Mazzoli S; Meacci F; Boddi V; Mondaini N; Malossini G; Bartoletti R
J Microbiol; 2011 Jun; 49(3):448-54. PubMed ID: 21717331
[TBL] [Abstract][Full Text] [Related]
15. Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.
Schaeffer AJ; Wu SC; Tennenberg AM; Kahn JB
J Urol; 2005 Jul; 174(1):161-4. PubMed ID: 15947609
[TBL] [Abstract][Full Text] [Related]
16. Comparison of results after fluoroquinolones and combination therapies in type IIIA chronic prostatitis.
Altintas R; Oguz F; Beytur A; Ediz C; Gunes A; Ozer A
Actas Urol Esp; 2013; 37(10):619-24. PubMed ID: 23768504
[TBL] [Abstract][Full Text] [Related]
17. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States.
Croom KF; Goa KL
Drugs; 2003; 63(24):2769-802. PubMed ID: 14664657
[TBL] [Abstract][Full Text] [Related]
18. Escherichia coli Nissle 1917 as adjuvant therapy in patients with chronic bacterial prostatitis: a non-blinded, randomized, controlled trial.
Manfredi C; Calace FP; Fusco F; Quattrone C; Giordano D; Crocetto F; Creta M; De Sio M; Arcaniolo D
World J Urol; 2021 Dec; 39(12):4373-4379. PubMed ID: 34213584
[TBL] [Abstract][Full Text] [Related]
19. Fosfomycin trometamol and N-acetyl-L-cysteine as combined oral therapy of difficult-to-treat chronic bacterial prostatitis: Results of a pilot study.
Cai T; Tamanini I; Mattevi D; Verze P; Palmieri A; Malossini G; Mirone V; Novelli A; Tascini C; Johansen TEB
Int J Antimicrob Agents; 2020 Jul; 56(1):105935. PubMed ID: 32156620
[TBL] [Abstract][Full Text] [Related]
20. Treatment for chronic prostatitis/chronic pelvic pain syndrome: levofloxacin, doxazosin and their combination.
Jeong CW; Lim DJ; Son H; Lee SE; Jeong H
Urol Int; 2008; 80(2):157-61. PubMed ID: 18362485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
